Biodistribution and internal radiation dosimetry of a companion diagnostic radiopharmaceutical, [68Ga]PSMA-11, in subcutaneous prostate cancer xenograft model mice
Abstract [68Ga]PSMA-11 is a prostate-specific membrane antigen (PSMA)-targeting radiopharmaceutical for diagnostic PET imaging. Its application can be extended to targeted radionuclide therapy (TRT). In this study, we characterize the biodistribution and pharmacokinetics of [68Ga]PSMA-11 in PSMA-pos...
Guardado en:
Autores principales: | Su Bin Kim, In Ho Song, Yoo Sung Song, Byung Chul Lee, Arun Gupta, Jae Sung Lee, Hyun Soo Park, Sang Eun Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b8ba989a518749f694bb6f9f3502d7a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
In vitro and in vivo comparative study of a novel 68Ga-labeled PSMA-targeted inhibitor and 68Ga-PSMA-11
por: Huanyu Chen, et al.
Publicado: (2021) -
Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach
por: Hanane Lahnif, et al.
Publicado: (2021) -
Biodistribution of 68/67Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging
por: Díez-Villares S, et al.
Publicado: (2021) -
Design and synthesis of a new conjugate of a tris(3-hydroxy-4-pyridinone) chelator (KC18) for potential use as gallium-68-labeled prostate-specific membrane antigen (PSMA) radiopharmaceutical
por: Xu Zhou, et al.
Publicado: (2021) -
Accuracy of standard clinical 3T prostate MRI for pelvic lymph node staging: Comparison to 68 Ga-PSMA PET-CT
por: Sebastian Meißner, et al.
Publicado: (2019)